This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1991 Apr;100(4):1157-64.

doi: 10.1016/0016-5085(91)90317-e.

Omeprazole and the induction of human cytochrome P-450: a response to concerns about potential adverse effects

A Parkinson, A Hurwitz

PMID: 2001824
DOI: 10.1016/0016-5085(91)90317-e

Review

Omeprazole and the induction of human cytochrome P-450: a response to concerns about potential adverse effects

A Parkinson et al. Gastroenterology. 1991 Apr.

. 1991 Apr;100(4):1157-64.

doi: 10.1016/0016-5085(91)90317-e.

Authors

A Parkinson, A Hurwitz

PMID: 2001824
DOI: 10.1016/0016-5085(91)90317-e

No abstract available

PubMed Disclaimer

Similar articles

[Omeprazole and the cytochrome P450 system of the liver].
Petersen KU. Petersen KU. Leber Magen Darm. 1993 Sep;23(5):186-92. Leber Magen Darm. 1993. PMID: 8412467 Review. German.
Omeprazole and aryl hydrocarbon hydroxylases: should we be worried?
Kolars JC, Turgeon DK, Watkins PB. Kolars JC, et al. Hepatology. 1991 Jan;13(1):197-9. doi: 10.1002/hep.1840130131. Hepatology. 1991. PMID: 1988343 No abstract available.
Omeprazole does not enhance the metabolism of phenacetin, a marker of CYP1A2 activity, in healthy volunteers.
Xiaodong S, Gatti G, Bartoli A, Cipolla G, Crema F, Perucca E. Xiaodong S, et al. Ther Drug Monit. 1994 Jun;16(3):248-50. doi: 10.1097/00007691-199406000-00004. Ther Drug Monit. 1994. PMID: 8085279
Warfarin therapy: how the less interesting half just got interesting.
Miller GP. Miller GP. J Thromb Haemost. 2010 Dec;8(12):2705-7. doi: 10.1111/j.1538-7836.2010.04097.x. J Thromb Haemost. 2010. PMID: 21138521 No abstract available.
Human cytochrome P450 isoforms. Their genetic heterogeneity and induction by omeprazole.
Farrell GC, Murray M. Farrell GC, et al. Gastroenterology. 1990 Sep;99(3):885-9. Gastroenterology. 1990. PMID: 2199294 Review. No abstract available.

See all similar articles

Cited by

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
Andersson T. Andersson T. Clin Pharmacokinet. 1996 Jul;31(1):9-28. doi: 10.2165/00003088-199631010-00002. Clin Pharmacokinet. 1996. PMID: 8827397 Review.
Risk-benefit assessment of omeprazole in the treatment of gastrointestinal disorders.
Creutzfeldt W. Creutzfeldt W. Drug Saf. 1994 Jan;10(1):66-82. doi: 10.2165/00002018-199410010-00005. Drug Saf. 1994. PMID: 8136088 Review.
Omeprazole inhibits growth of cancer cell line of colonic origin.
Tobi M, Chintalapani S, Goo R, Maliakkal B, Reddy J, Lundqvist M, Oberg K, Luk G. Tobi M, et al. Dig Dis Sci. 1995 Jul;40(7):1526-30. doi: 10.1007/BF02285203. Dig Dis Sci. 1995. PMID: 7628278
Laparoscopic Nissen fundoplication: two-year comprehensive follow-up of a technique of minimal paraesophageal dissection.
Anvari M, Allen C. Anvari M, et al. Ann Surg. 1998 Jan;227(1):25-32. doi: 10.1097/00000658-199801000-00004. Ann Surg. 1998. PMID: 9445106 Free PMC article.
Omeprazole and lansoprazole are not inducers of cytochrome P4501A2 under conventional therapeutic conditions.
Rizzo N, Padoin C, Palombo S, Scherrmann JM, Girre C. Rizzo N, et al. Eur J Clin Pharmacol. 1996;49(6):491-5. doi: 10.1007/BF00195936. Eur J Clin Pharmacol. 1996. PMID: 8706775 Clinical Trial.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Elsevier Science